CXCR3 and Kawasaki disease: Based on these theories, reducing the level of IFN-γ and preventing these kinds of CD4 + CXCR3+ T cells from infiltrating the coronary arterial wall may be useful in the treatment of Kawasaki disease and prevention of CALs.